Evamist.com

A low-dose estrogen therapy

Evamist contains low dose 17ß-estradiol, an estrogen chemically synthesized from a plant source.¹ This does not mean Evamist is safer or more effective than other hormone therapies.

Women found Evamist easy to use

In the same study, convenience was the #1 Evamist attribute women found important.^†1 On a scale from 1 to 9, with 9 being very easy to use, Evamist was ranked 8.3 for ease of use.¹ With advantages like these…it’s no wonder women feel Evamist is convenient:

Cannot be seen or felt after application¹
No need to touch the medication when applying²
Low site irritation and no residue¹
Dries in a median of 67 seconds¹
Covers a small area of skin^1,2

After applying Evamist, simply wait at least 2 minutes before dressing and at least 30 minutes before washing. Others should not make contact with the application area for at least 30 minutes after application.²

Furthermore, among women who had previously used an estrogen patch,
3 out of 4 reported that Evamist was more convenient than their previous patch therapy.^‡1

Higher satisfaction compared to previous estrogen therapies

Surveyed patients were very satisfied with the relief they experienced with Evamist (92% of these patients used 1 or 2 sprays per day).^§1 And they were more satisfied overall versus previously used estrogen therapies including patches, pills, lotions, and gels.^||1

Evamist can give you what you want out of an estrogen therapy. Talk to your doctor today to see if Evamist is right for you.

» References

*	As reported in an experience study of 247 women using Evamist.¹
†	As reported in an experience study of 247 women using Evamist. In this study, the majority of women ranked convenience higher in importance than any other Evamist attribute.¹
‡	As reported in an experience study of 247 women using Evamist, 53 of whom were previous patch users.¹
§	As reported in an experience study of 247 women using Evamist. Patients were asked, “Since starting Evamist, how satisfied are you with the relief from hot flashes?” Evamist was ranked 7.3 out of 9 in satisfaction for hot flash relief.¹
\|\|	As reported in an experience study of 247 women using Evamist, 157 of whom had previously used another form of estrogen therapy.¹

Important Safety Information

Evamist^® is approved by the FDA for use after menopause to reduce moderate-to-severe hot flashes.

Estrogens increase the chance of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are using Evamist. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus. Your healthcare provider should check any unusual vaginal bleeding to find out the cause.

Do not use estrogens with or without progestins to prevent heart disease, heart attacks, strokes, or dementia. Using estrogens, with or without progestins, may increase your chance of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogen, with or without progestins, may increase your risk of dementia, based on a study of women age 65 years or older. Evamist should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the past year; currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.

The most common side effects that may occur with Evamist are headache, breast tenderness, the common cold, nipple pain, back pain, nausea, and joint pain.

You and your healthcare provider should talk regularly about whether you still need treatment with Evamist.

Please see full prescribing information for Evamist.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.